Contra-indicated in pregnancy, with concurrent use of simvastatin or lovastatin and CYP3A substrates with narrow therapeutic range or long-term corticosteroid use, and in women with a history of unexplained vaginal bleeding or with endometrial hyperplasia with atypia or endometrial carcinoma.
- TRADE NAMES: Korlym (Corcept); Mifeprex (Danco)
- INDICATIONS: Medical termination of intrauterine pregnancy (Mifeprex); Cushing's syndrome in patients with Type II diabetes (Korlym)
- CLASS: Corticosteroid antagonist, CYP3A4 inhibitor, Progestogen antagonist
- HALF-LIFE: 85 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amprenavir, Aprepitant, Atazanavir, Boceprevir, Bupropion, Carbamazepine, Ciclesonide, Ciprofloxacin, Clarithromycin, Conivaptan, Cyclosporine, Darunavir, Dihydroergotamine, Diltiazem, Efavirenz, Ergotamine, Erythromycin, Fentanyl, Fluconazole, Fluvastatin, Fosamprenavir, Grapefruit Juice, Imatinib, Indinavir, Itraconazole, Lopinavir, Lovastatin, Mibefradil, Nefazodone, Nelfinavir, NSAIDs, Oral Contraceptives, Phenobarbital, Phenytoin, Pimozide, Posaconazole, Quinidine, Repaglinide, Rifabutin, Rifampin, Rifapentine, Ritonavir, Ritonavir, Saquinavir, Simvastatin, Sirolimus, St John's Wort, Tacrolimus, Telaprevir, Telithromycin, Tenoxicam, Triamcinolone, Verapamil, Voriconazole, Warfarin
TERMINATION OF PREGNANCY
See full prescribing information for complete boxed warning.
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
